Cantor Fitzgerald’s Jim Shiggins: Why I Invested in SyndicateRoom’s Hibergene Campaign
Today Hibergene‘s Series B funding round on SyndicateRoom will successfully close at midnight tonight, having raised at least £5,707,336 with the help of over 53 investors. Funds will be used to support R&D activities to launch three new products in 2017. The Irish medical diagnostics company specializes in the urgent diagnosis… Read More
Read more in: General News, Global, Offerings, Opinion | Tagged biotech, cantor fitzgerald, ireland, jim shiggins, medtech